Erika Morsia

8PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersMedical mycologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)BiomaterialsVenereology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 11, 2026
A dynamic prognostic model for polycythemia vera long-term outcomes in patients treated with ruxolitinib.

|Feb 21, 2026
Overall survival with momelotinib vs. best available therapy in patients with ruxolitinib-experienced myelofibrosis: a matching-adjusted indirect comparison.

Francesca Palandri, Venediktos Kapetanakis, Balázs Dobi

|Dec 17, 2024
Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations.

Alberto Carturan, Sonia Morè, Antonella Poloni

|May 10, 2024
Bone Marrow Adipose Tissue.

Elena Marinelli Busilacchi, Erika Morsia, Antonella Poloni

|Dec 18, 2023
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.

Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale

|May 14, 2022
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications.

Erika Morsia, Elena Torre, Antonella Poloni

Pageof 2

Frequent Collaborators

3 joint publications

Antonella Poloni

3 joint publications

Massimo Breccia

2 joint publications

Filippo Branzanti

2 joint publications

Mario Tiribelli